The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results

European Urology

Volumn 70, Issue 3, 2016, Pages 506-515

  Naito, Seiji ^a   Algaba, Ferran ^b   Babjuk, Marko ^c   Bryan, Richard T ^d   Sun, Ying Hao ^e   Valiquette, Luc ^f   de la Rosette, Jean ^g  

^a HARASANSHIN HOSPITAL   (Japan)

^b FUNDACIÓ PUIGVERT   (Spain)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Narrow band imaging; Non muscle invasive bladder cancer; Transurethral resection of bladder tumour; Tumour recurrence; White light imaging

Indexed keywords

ACUTE ABDOMEN; ADULT; AGED; ARTICLE; BLADDER CRAMP; BLADDER DISEASE; BLADDER PERFORATION; CANCER RECURRENCE; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTECTOMY; DEEP VEIN THROMBOSIS; FEMALE; FEVER; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENTION TO TREAT ANALYSIS; INTERMEDIATE RISK PATIENT; INTERMETHOD COMPARISON; LOW RISK PATIENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTICENTER STUDY; NARROW BAND IMAGING; NARROW BAND IMAGING ASSISTED TRANSURETHRAL RESECTION OF BLADDER TUMOR; NON MUSCLE INVASIVE BLADDER CANCER; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; REOPERATION; SEPSIS; SINGLE BLIND PROCEDURE; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; WHITE LIGHT; WHITE LIGHT IMAGING ASSISTED TRANSURETHRAL RESECTION OF BLADDER TUMOR; ADOLESCENT; BLADDER TUMOR; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ETIOLOGY; LIGHT; MIDDLE AGED; PATHOLOGY; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; NARROW BAND IMAGING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84964620302     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.03.053     Document Type: Article

References (27)

1. [1] Babjuk M, Böhle A, Burger M, et al. Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). European Association of Urology Web site. http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.
2. [2] Kriegmair, M., Baumgartner, R., Knühel, R., Stepp, H., Hofstädter, F., Hofstetter, A., Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155 (1996), 105–109.
3. [3] Jichlinski, P., Forrer, M., Mizeret, J., et al. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20 (1997), 402–408.
4. [4] Bryan, R.T., Collins, S.I., Daykin, M.C., et al. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl 92 (2010), 519–524.
5. [5] Mannath, J., Subramanian, V., Hawkey, C.J., Ragunath, K., Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy 42 (2010), 351–359.
6. [6] Pasha, S.F., Leighton, J.A., Das, A., et al. Comparison of the yield and miss rate of narrow band imaging and white light endoscopy in patients undergoing screening or surveillance colonoscopy: a meta-analysis. Am J Gastroenterol 107 (2012), 363–370.
7. [7] Bryan, R.T., Billingham, L.J., Wallace, D.M., Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 101 (2008), 702–705.
8. [8] Naselli, A., Introini, C., Bertolotto, F., Spina, B., Puppo, P., Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 105 (2010), 208–211.
9. [9] Zheng, C., Lv, Y., Zhong, Q., Wang, R., Jiang, Q., Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int 110 (2012), E680–E687.
10. [10] Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
11. [11] Common Terminology Criteria for Adverse Events v3.0. (CTCAE). National Cancer Institute Cancer Therapy Evaluation Program Web site. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.
12. [12] Sylvester, R.J., van der Meijden, A.P., Oosterlinck, W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006), 466–477.
13. [13] Cauberg, E.C., Mamoulakis, C., de la Rosette, J.J., de Reijke, T.M., Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 29 (2011), 503–509.
14. [14] Mariappan, P., Finney, S.M., Head, E., et al., Edinburgh Urological Cancer Group. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int 109 (2012), 1666–1673.
15. [15] Herr, H., Donat, M., Dalbagni, G., Taylor, J., Narrow-band imaging cystoscopy to evaluate bladder tumours-individual surgeon variability. BJU Int 106 (2010), 53–55.
16. [16] Rink, M., Babjuk, M., Catto, J.W., et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol 64 (2013), 624–638.
17. [17] Tatsugami, K., Kuroiwa, K., Kamoto, T., et al. Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 24 (2010), 1807–1811.
18. [18] Geavlete, B., Jecu, M., Multescu, R., Geavlete, P., Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach. Ther Adv Urol 4 (2012), 211–217.
19. [19] Jecu, M., Geavlete, B., Mulţescu, R., et al. NBI cystoscopy in routine urological practice - from better vision to improve therapeutic management. J Med Life 7 (2014), 282–286.
20. [20] Cauberg, E.C., Kloen, S., Visser, M., et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology 76 (2010), 658–663.
21. [21] Chen, G., Wang, B., Li, H., Ma, X., Shi, T., Zhang, X., Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder. Urol Oncol 31 (2013), 475–479.
22. [22] Li, K., Lin, T., Fan, X., Duan, Y., Huang, J., Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol 20 (2013), 602–609.
23. [23] Herr, H.W., Donat, S.M., Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU Int 107 (2011), 396–398.
24. [24] Montanari, E., de la Rosette, J., Longo, F., Del Nero, A., Laguna, P., Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer. Arch Ital Urol Androl 84 (2012), 179–183.
25. [25] Naselli, A., Introini, C., Timossi, L., et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol 61 (2012), 908–913.
26. [26] Witjes, J.A., Redorta, J.P., Jacqmin, D., et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 57 (2010), 607–614.
27. [27] O'Brien, T., Ray, E., Chatterton, K., Khan, M.S., Chandra, A., Thomas, K., Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. BJU Int 112 (2013), 1096–1104.